CAD 0.34
(1.49%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.09 CAD | 67.9% |
2022 | -0.29 CAD | 29.27% |
2021 | -0.41 CAD | 63.39% |
2020 | -1.12 CAD | -0.9% |
2019 | -1.11 CAD | -146.67% |
2018 | -0.45 CAD | -136.84% |
2017 | -0.19 CAD | -6937.04% |
2016 | -0.00 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.01 CAD | 69.37% |
2024 Q2 | -0.02 CAD | -139.08% |
2023 Q4 | -0.03 CAD | -74.23% |
2023 FY | - CAD | 67.9% |
2023 Q3 | -0.02 CAD | 22.75% |
2023 Q2 | -0.02 CAD | 35.28% |
2023 Q1 | -0.03 CAD | 67.4% |
2022 Q1 | -0.02 CAD | 90.25% |
2022 FY | - CAD | 29.27% |
2022 Q4 | -0.10 CAD | -105.76% |
2022 Q3 | -0.05 CAD | 55.82% |
2022 Q2 | -0.11 CAD | -464.1% |
2021 Q2 | -0.07 CAD | 21.43% |
2021 FY | - CAD | 63.39% |
2021 Q1 | -0.09 CAD | 78.65% |
2021 Q4 | -0.20 CAD | -209.12% |
2021 Q3 | -0.06 CAD | 3.58% |
2020 Q3 | -0.25 CAD | 10.71% |
2020 Q2 | -0.28 CAD | -133.33% |
2020 FY | - CAD | -0.9% |
2020 Q1 | -0.12 CAD | 52.0% |
2020 Q4 | -0.40 CAD | -60.0% |
2019 Q4 | -0.25 CAD | 10.71% |
2019 Q3 | -0.28 CAD | -33.33% |
2019 FY | - CAD | -146.67% |
2019 Q2 | -0.21 CAD | 12.5% |
2019 Q1 | -0.24 CAD | 0.0% |
2018 Q2 | -0.09 CAD | -702.56% |
2018 FY | - CAD | -136.84% |
2018 Q4 | -0.24 CAD | -84.62% |
2018 Q3 | -0.13 CAD | -38.45% |
2018 Q1 | -0.01 CAD | 91.0% |
2017 Q4 | -0.13 CAD | -128.47% |
2017 FY | - CAD | -6937.04% |
2017 Q3 | -0.06 CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Aurora Cannabis Inc. | -1.60 CAD | 94.181% |
Avant Brands Inc. | -0.61 CAD | 84.738% |
Cardiol Therapeutics Inc. | -0.44 CAD | 78.841% |
Crescita Therapeutics Inc. | -0.10 CAD | 5.0% |
Knight Therapeutics Inc. | -0.16 CAD | 41.813% |
MediPharm Labs Corp. | -0.04 CAD | -158.611% |
OrganiGram Holdings Inc. | -2.82 CAD | 96.699% |
Canopy Growth Corporation | -8.79 CAD | 98.941% |
Willow Biosciences Inc. | -0.10 CAD | 6.9% |
Auxly Cannabis Group Inc. | -0.04 CAD | -107.35% |